|
Aspen Receives US $1 Million In Transfer of Technology Agreement
|
|
03 February 2010
|
|
|
|
Johannesburg - Eli Lilly today announced the US$1 million milestone payment to Aspen, South Africa’s leading pharmaceutical manufacturer, as part of the joint collaboration on expanding access to medicines to treat multidrug-resistant tuberculosis (MDR-TB).
|
|
Read more »
|
|
Aspen’s revenue increases by 80 percent as international business expands
|
|
08 September 2009
|
|
|
|
Johannesburg - JSE listed Aspen Pharmacare Holdings Limited, Africa’s largest pharmaceutical manufacturer, has produced excellent results for the year ended 30 June 2009. Prevailing global economic conditions did little to deter the strength of the Group’s performance, with the South African and Australian businesses continuing to perform well. Aspen’s international expansions resulted in substantially increased contributions from the offshore businesses, delivering an operating profit of R1.076
|
|
Read more »
|
|
Aspen’s S26 Assurance of Quality
|
|
07 September 2009
|
|
|
|
“At Aspen we understand that the wellbeing of your baby is of utmost importance. I confidently give you my assurance that Aspen’s S26 infant milk formula available to you in South Africa is of the highest quality. My confidence is based on these facts:
|
|
Read more »
|
|
Quality of S-26 in South Africa Guaranteed
|
|
30 August 2009
|
|
|
|
Johannesburg: Aspen Nutritionals, manufacturer of S-26 and other infant milk formulations (IMFs), confirms that all IMFs manufactured and marketed by Aspen Nutritionals are safe for infant consumption.
|
|
Read more »
|
|
NOTIFICATION ON RELEASING OF FINANCIAL RESULTS
|
|
25 August 2009
|
|
|
|
Aspen will be releasing financial results for the year ended June 30, 2009 on September 8, 2009 and not on August 28 as indicated by certain media. We apologise for any inconvenience which this may have caused you.
|
|
Read more »
|